secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0000012208-24-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad discloses Sartorius AG FY 2023 results: revenue €3.4B, net profit €290M
-------------------------------------------------------------------------------

- Sartorius AG FY 2023 sales revenue €3,395.7M, gross profit €1,567.1M.
- EBIT €503.9M, net profit €290.0M for the year ended Dec 31, 2023.
- Operating cash flow €853.6M; investing cash flow -€2,823.3M; financing cash flow €2,165.7M.
- Total assets €9,755.4M, equity €2,757.4M as of Dec 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000015/0000012208-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000015/bio-20240221.htm
  HTML page:      https://secwatch.observer/filing/0000012208-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer